Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Restructuring Costs (2024)

Historic Restructuring Costs for Amylyx Pharmaceuticals (AMLX) over the last 1 years, with Q2 2024 value amounting to $22.9 million.

  • Amylyx Pharmaceuticals' Restructuring Costs changed N/A to $22.9 million in Q2 2024 from the same period last year, while for Jun 2025 it was $22.9 million, marking a year-over-year change of. This contributed to the annual value of $22.9 million for FY2024, which is N/A changed from last year.
  • Amylyx Pharmaceuticals' Restructuring Costs amounted to $22.9 million in Q2 2024.
  • Amylyx Pharmaceuticals' Restructuring Costs' 5-year high stood at $22.9 million during Q2 2024, with a 5-year trough of $22.9 million in Q2 2024.